Showing papers by "Robert J. Fontana published in 2004"

TL;DR: Emerging evidence suggests that hepatitis B virus (HBV) genotypes may influence the rate of spontaneous and interferon-induced hepatitis B e antigen (HBeAg) seroconversion as well as the natural history of liver disease.

TL;DR: Combined antiviral therapy in treatment-naive chronic hepatitis C patients was of similar efficacy to that reported in large multicenter trials, and data show that medication adherence is an important predictor of SVR in an academic clinical practice.

TL;DR: Decisions regarding retreatment with PEG IFN and RBV should be made on a case-by-case basis after considering the tolerability of prior treatment, the severity of underlying liver disease, and the anticipated likelihood of response.